University of California Davis (UCDAVIS)

University / College


Location: Davis, CA, United States (USA) (US) US

ISNI: 0000000419369684

ROR: https://ror.org/05rrcem69

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Discovery of several thousand highly diverse circular DNA viruses (2020) Tisza MJ, Pastrana DV, Welch NL, Stewart B, Peretti A, Starrett GJ, Pang YYS, et al. Journal article Safety and effectiveness of ataluren: comparison of results from the STRIDE Registry and CINRG DMD Natural History Study. (2020) Mercuri E, Muntoni F, Osorio AN, Tulinius M, Buccella F, Morgenroth LP, Gordish-Dressman H, et al. Journal article Optimizing Sparsity over Lattices and Semigroups (2020) Aliev I, Averkov G, De Loera JA, Oertel T Conference contribution Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer (2020) Kho PF, Amant F, Annibali D, Ashton K, Attia J, Auer PL, Beckmann M, et al. Journal article Long-Term Obeticholic Acid Therapy Improves Histological Endpoints in Patients With Primary Biliary Cholangitis (2020) Bowlus CL, Pockros PJ, Kremer A, Parés A, Forman LM, Drenth JP, Ryder SD, et al. Journal article Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases (2020) Lynch KD, Chapman RW, Keshav S, Montano-Loza AJ, Mason AL, Kremer A, Vetter M, et al. Journal article Autofluorescence lifetime augmented reality as a means for real-time robotic surgery guidance in human patients (2019) Gorpas D, Phipps J, Bec J, Ma D, Dochow S, Yankelevich D, Sorger J, et al. Journal article THE NOX1/4 INHIBITOR GKT831 ACHIEVES CLINICALLY MEANINGFUL REDUCTIONS IN LIVER STIFFNESS, ATTENUATES CHOLESTASIS, AND IMPROVES QUALITY OF LIFE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (2019) Huang JC, Invernizzi P, Dalekos GN, Nevens F, Van Vlierberghe H, Zigmond E, Andrade RJ, et al. Conference contribution Pathogenic WDFY3 variants cause neurodevelopmental disorders and opposing effects on brain size (2019) Le Duc D, Giulivi C, Hiatt SM, Napoli E, Panoutsopoulos A, De Crescenzo A, Kotzaeridou U, et al. Conference contribution Pathogenic WDFY3 variants cause neurodevelopmental disorders and opposing effects on brain size (2019) Le Duc D, Giulivi C, Hiatt SM, Napoli E, Panoutsopoulos A, Harlan De Crescenzo A, Kotzaeridou U, et al. Journal article
1 2 3 4 5 6 ... 9